FT Health: The dangers of data
The Financial Times’ monthly global health and finance newsletter highlights how “technology has proved valuable during the coronavirus pandemic in helping rapidly collect and analyze information for clinicians, drug developers, and policymakers alike. But it has also contributed to an ‘infodemic’ of distorted analysis, fueling misleading information and a politicization of prevention measures, from lockdowns to the wisdom of wearing face masks.” The newsletter also features an interview with epidemiology expert David Heymann and a roundup of global health-related news stories (Jack/Dodd, 11/4).